About Us
Submissions
Advertising
SIGN IN
|
SUBSCRIBE
ISSUE
CURRENT
ARCHIVE
SUPPLEMENTS
JADPRO LIVE
2020
JADPRO Live 2019 Activities
JADPRO Live 2018 Activities
CE
QUICK TIPS
SPECIAL CONTENT
Expert Conversations
Clinical Case Series
Roundtable Series: Multiple Myeloma
Cardio-Oncology Updates
MPN Resource Center
APSHO Educator Modules
HIGHLIGHTS
PODCAST
Learn more on this topic:
Advances in Extended Adjuvant HER2-Positive Early Breast Cancer
How do I select patients for treatment with extended adjuvant therapies such as neratinib?
G. Thomas Budd, MD
G. Thomas Budd, MD, on advances in extended adjuvant HER2+ early breast cancer.
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.
